Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds CABACABALETTA BIO

7 funds on our shelf carry CABALETTA BIO — heaviest hand: SURI at 1.01% of its book.

FundWeightFund assetsShares held
SURISimplify Propel Opportunities ETFACTIVE1.01%$75M556,235
BBCVirtus Biotech Clinical Trials ETF0.34%—83,144
XBIState Street SPDR S&P Biotech ETFINDEX0.06%$10.3B5,102,003
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.01%$112M13,864
IBBiShares Biotechnology ETFINDEX0.01%$10.6B1,120,151
LABUDirexion Daily S&P Biotech Bull 3X ETFINDEX0.01%$624M189,531
BIBProShares Ultra Nasdaq BiotechnologyINDEX0.01%$92M7,117

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.